Skip to main content
. 2015 Apr 1;8(4):3636–3647.

Table 1.

Characteristics and follow-up data of 46 cases of RCC

No Type Gender/age pTNM Stage Follow up Survival time (years)
1 CCRCC F/31 T2M0N0 2 survive 14
2 CCRCC F/25 T1M0N0 1 Death 21
3 CCRCC M/52 T2M0N0 2 Death 20
4 CCRCC M/39 T2M0N0 2 Survive 18
5 CCRCC M/56 T1M0N0 1 Survive 17
6 CCRCC M/55 T3M0N0 3 Death 1
7 CCRCC M/39 T3M0N0 3 Survive 10
8 CCRCC F/74 T2M0N0 2 Survive 9
9 CCRCC M/70 T2M0N0 2 Survival 8
10 CCRCC M/70 T2M1NO 4 Death 16
11 Type 1 PRCC M/62 T1M0N0 1 Survival 18
12 Type 1 PRCC M/49 T2M0N0 2 Death 13
13 Type 1 PRCC F/61 T2M0N0 2 Survival 13
14 Type 1 PRCC M/36 T1M0N0 1 Survival 10
15 Type 1 PRCC F/48 T2M0N0 2 Survival 6
16 Type 1 PRCC M/52 T2M0N0 2 Survival 3
17 Type 2 PRCC M/58 T3M0N0 3 Death 29
18 Type 2 PRCC F/56 T2M0N0 2 Death 29
19 Type 2 PRCC M/70 T3M0N0 3 Death 2
20 Type 2 PRCC M/53 T2M0N0 2 Death 5
21 Type 2 PRCC F/55 T2M0N1 3 Death 7
22 Type 2 PRCC M/61 T2M1N0 4 Death 4
23 Type 2 PRCC M/88 T2M1N0 4 Death 4
24 CRCC C F/52 T2M0N0 2 Death 34
25 CRCC C F/36 T1M0N0 1 Survival 19
26 CRCC C M/42 T1M0N0 1 Survival 16
27 CRCC C F/72 T3M0N0 3 Death 15
28 CRCC C M/32 T1M0N0 1 Survival 13
29 CRCC C F/74 T2M0N0 2 Survival 9
30 CRCC C F/30 T1M0N1 3 Death 5
31 CRCC C M/36 T2M0N0 2 Survival 7
32 CRCC S M/25 T3M0N1 3 Death 34
33 CRCC S F/32 T4M0N0 4 Death 13
34 CRCC S M/75 T2M1NO 4 Death 11
35 CRCC S M/64 T2M1N1 4 Death 10
36 Xp11.2RCC M/26 T2M0N0 2 Death 37
37 Xp11.2RCC M/47 T3MONO 3 Death 36
38 Xp11.2RCC F/47 T2M0N0 2 Death 26
39 Xp11.2RCC M/85 T3MON0 3 Survival 9
40 Xp11.2RCC M/43 T1M0N1 4 Death 8
41 Xp11.2RCC M/64 T1M0N0 1 Death 8
42 Xp11.2RCC M/72 T2M1NI 4 Death 5
43 Xp11.2RCC F/63 T2M1NO 4 Survival 4
44 Xp11.2RCC F/72 T2M0N1 4 Survival 5
45 UnRCC M/56 T3MONO 3 Death 2
46 UnRCC M/60 T3M1NO 3 Death 3